COMMUNIQUÉS West-GlobeNewswire
-
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/11/2026 -
PacBio to Participate in the Piper Sandler 38th Annual Healthcare Conference
17/11/2026 -
CVRx to Participate at the Piper Sandler 38th Annual Healthcare Conference
17/11/2026 -
CytomX Therapeutics Announces Milestone Achievement in Strategic Collaboration with Regeneron in the Field of Conditionally Activated Bispecifics
17/11/2026 -
Gain Therapeutics Presents Clinical Data from Phase 1b Study of Rexaceract and Preclinical Data from Novel GCase Modulator GT-04686
17/11/2026 -
InspireMD to Host KOL Webinar on Carotid Artery Disease Management and the Clinical Benefits of InspireMD’s CGuard Prime Carotid Stent Platform
17/11/2026 -
Biogen’s Diranersen Demonstrates Increasing Clinical Benefit at Two Years in Early Alzheimer’s Disease
17/11/2026 -
BioSyent Declares Fourth Quarter 2026 Dividend
17/11/2026 -
BioSyent Releases Financial Results for Q3 and YTD 2026
17/11/2026 -
Portsmouth Square, Inc. Reports First Quarter Fiscal 2027 Results; Pedestrian Bridge Removal Complete and Hotel Reopened After City-Mandated Closure
17/11/2026 -
Erasca Enters into Clinical Collaboration with Bristol Myers Squibb to Evaluate ERAS-0015 in Clinical Study with Navlimetostat
18/11/2026 -
Non-Surgical Hair Restoration in NYC: Park Avenue Practice Opens Dedicated GLP-1 Hair Loss Assessments for January, With Procedure Decided Only After Blood Work
17/11/2026 -
COP31 : l’EAACI appelle à intégrer les allergies et la santé respiratoire dans les politiques de lutte contre le changement climatique
17/11/2026 -
MATTER Honors Companies Turning Employee Activation Into Community Impact
17/11/2026 -
Priavoid Announces Topline Phase 2 Data for Oral All-D-Peptide PRI-002 in Alzheimer’s Disease at CTAD 2026
17/11/2026 -
Dazed, Inc. Reports 72.5% Gross Margin and 121% Royalty Growth as Texas Lawmakers File Adult-Use Cannabis Bills in Home Market
17/11/2026 -
Newly Launched CuraeChoice Platform Unlocks Healthcare Pricing Visibility for Nearly 370,000 Employers by Tax ID Alone
17/11/2026 -
Terumo Neuro Announces Publication of RESTORE Registry Results in the Journal of NeuroInterventional Surgery
17/11/2026 -
Acoramidis Was Associated with Lower Risk of Worsening Heart Failure Versus Tafamidis in Real-World Study and Reduced Heart Failure Events Within One Month in ATTRibute-CM
17/11/2026
Pages